25 XP   0   0   10

NeuPath Health Inc
Buy, Hold or Sell?

Let's analyse Neupath together

PenkeI guess you are interested in NeuPath Health Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of NeuPath Health Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about NeuPath Health Inc

I send you an email if I find something interesting about NeuPath Health Inc.

Quick analysis of Neupath (30 sec.)










What can you expect buying and holding a share of Neupath? (30 sec.)

How much money do you get?

How much money do you get?
C$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
C$0.39
Expected worth in 1 year
C$0.37
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
C$-0.02
Return On Investment
-13.6%

For what price can you sell your share?

Current Price per Share
C$0.17
Expected price per share
C$0.17 - C$0.195
How sure are you?
50%

1. Valuation of Neupath (5 min.)




Live pricePrice per Share (EOD)

C$0.17

Intrinsic Value Per Share

C$0.77 - C$0.93

Total Value Per Share

C$1.16 - C$1.32

2. Growth of Neupath (5 min.)




Is Neupath growing?

Current yearPrevious yearGrowGrow %
How rich?$16.3m$18.1m-$2.1m-13.6%

How much money is Neupath making?

Current yearPrevious yearGrowGrow %
Making money-$290.4k-$561.4k$270.9k93.3%
Net Profit Margin-2.5%-4.9%--

How much money comes from the company's main activities?

3. Financial Health of Neupath (5 min.)




4. Comparing to competitors in the Medical Care Facilities industry (5 min.)




  Industry Rankings (Medical Care Facilities)  


Richest
#146 / 187

Most Revenue
#154 / 187

Most Profit
#126 / 187

Most Efficient
#133 / 187

What can you expect buying and holding a share of Neupath? (5 min.)

Welcome investor! Neupath's management wants to use your money to grow the business. In return you get a share of Neupath.

What can you expect buying and holding a share of Neupath?

First you should know what it really means to hold a share of Neupath. And how you can make/lose money.

Speculation

The Price per Share of Neupath is C$0.17. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Neupath.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Neupath, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is C$0.39. Based on the TTM, the Book Value Change Per Share is C$-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is C$-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is C$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Neupath.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 C$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per Share
Usd Eps0.002.9%-0.01-3.0%-0.01-5.9%-0.01-6.3%-0.01-6.3%
Usd Book Value Change Per Share0.013.5%0.00-2.5%-0.01-6.2%0.0211.4%0.0211.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.013.5%0.00-2.5%-0.01-6.2%0.0211.4%0.0211.4%
Usd Price Per Share0.12-0.11-0.27-0.27-0.27-
Price to Earnings Ratio5.97-6.90--7.69--6.20--6.20-
Price-to-Total Gains Ratio19.74-5.15--29.24--25.14--25.14-
Price to Book Ratio0.41-0.40-0.82-0.86-0.86-
Price-to-Total Gains Ratio19.74-5.15--29.24--25.14--25.14-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.125171
Number of shares7989
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.02
Usd Total Gains Per Share0.000.02
Gains per Quarter (7989 shares)-33.90154.46
Gains per Year (7989 shares)-135.59617.85
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-136-1460618608
20-271-282012361226
30-407-418018541844
40-542-554024712462
50-678-690030893080
60-814-826037073698
70-949-962043254316
80-1085-1098049434934
90-1220-1234055615552
100-1356-1370061796170

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%2.010.00.016.7%2.013.00.013.3%2.013.00.013.3%2.013.00.013.3%
Book Value Change Per Share2.02.00.050.0%4.08.00.033.3%6.09.00.040.0%6.09.00.040.0%6.09.00.040.0%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.015.00.0%0.00.015.00.0%0.00.015.00.0%
Total Gains per Share2.02.00.050.0%4.08.00.033.3%6.09.00.040.0%6.09.00.040.0%6.09.00.040.0%

Fundamentals of Neupath

About NeuPath Health Inc

NeuPath Health Inc. provides chronic pain management services in Canada. The company offers chronic pain assessment and multi-modal treatment plan that helps patient to manage pain and optimize quality of life. It also provides workplace health services and independent medical assessments to employers and disability insurers through a national network of health care providers. The company is headquartered in Mississauga, Canada.

Fundamental data was last updated by Penke on 2024-03-11 11:38:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is cheap.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of NeuPath Health Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Neupath earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Neupath to the Medical Care Facilities industry mean.
  • A Net Profit Margin of 2.3% means that $0.02 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of NeuPath Health Inc:

  • The MRQ is 2.3%. The company is making a profit. +1
  • The TTM is -2.5%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ2.3%TTM-2.5%+4.8%
TTM-2.5%YOY-4.9%+2.5%
TTM-2.5%5Y-6.0%+3.5%
5Y-6.0%10Y-6.0%0.0%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ2.3%2.2%+0.1%
TTM-2.5%2.1%-4.6%
YOY-4.9%3.4%-8.3%
5Y-6.0%2.9%-8.9%
10Y-6.0%3.6%-9.6%
1.1.2. Return on Assets

Shows how efficient Neupath is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Neupath to the Medical Care Facilities industry mean.
  • 0.9% Return on Assets means that Neupath generated $0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of NeuPath Health Inc:

  • The MRQ is 0.9%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is -0.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ0.9%TTM-0.9%+1.8%
TTM-0.9%YOY-1.5%+0.7%
TTM-0.9%5Y-1.8%+1.0%
5Y-1.8%10Y-1.8%0.0%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9%0.7%+0.2%
TTM-0.9%0.6%-1.5%
YOY-1.5%1.0%-2.5%
5Y-1.8%0.8%-2.6%
10Y-1.8%1.0%-2.8%
1.1.3. Return on Equity

Shows how efficient Neupath is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Neupath to the Medical Care Facilities industry mean.
  • 1.7% Return on Equity means Neupath generated $0.02 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of NeuPath Health Inc:

  • The MRQ is 1.7%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is -1.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ1.7%TTM-1.8%+3.5%
TTM-1.8%YOY-3.1%+1.3%
TTM-1.8%5Y-4.1%+2.2%
5Y-4.1%10Y-4.1%0.0%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7%2.0%-0.3%
TTM-1.8%2.1%-3.9%
YOY-3.1%2.5%-5.6%
5Y-4.1%2.1%-6.2%
10Y-4.1%2.5%-6.6%

1.2. Operating Efficiency of NeuPath Health Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Neupath is operating .

  • Measures how much profit Neupath makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Neupath to the Medical Care Facilities industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of NeuPath Health Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.2%+0.2%
TTM-0.2%YOY-3.1%+2.9%
TTM-0.2%5Y-1.7%+1.5%
5Y-1.7%10Y-1.7%0.0%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.9%-7.9%
TTM-0.2%6.8%-7.0%
YOY-3.1%6.6%-9.7%
5Y-1.7%6.4%-8.1%
10Y-1.7%8.0%-9.7%
1.2.2. Operating Ratio

Measures how efficient Neupath is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Care Facilities industry mean).
  • An Operation Ratio of 1.82 means that the operating costs are $1.82 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of NeuPath Health Inc:

  • The MRQ is 1.817. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.814. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.817TTM1.814+0.003
TTM1.814YOY1.857-0.043
TTM1.8145Y1.830-0.016
5Y1.83010Y1.8300.000
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8171.166+0.651
TTM1.8141.128+0.686
YOY1.8570.990+0.867
5Y1.8301.019+0.811
10Y1.8301.001+0.829

1.3. Liquidity of NeuPath Health Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Neupath is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Care Facilities industry mean).
  • A Current Ratio of 1.06 means the company has $1.06 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of NeuPath Health Inc:

  • The MRQ is 1.064. The company is just able to pay all its short-term debts.
  • The TTM is 0.924. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ1.064TTM0.924+0.140
TTM0.924YOY0.989-0.065
TTM0.9245Y1.035-0.111
5Y1.03510Y1.0350.000
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0641.286-0.222
TTM0.9241.308-0.384
YOY0.9891.383-0.394
5Y1.0351.386-0.351
10Y1.0351.413-0.378
1.3.2. Quick Ratio

Measures if Neupath is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Neupath to the Medical Care Facilities industry mean.
  • A Quick Ratio of 0.70 means the company can pay off $0.70 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of NeuPath Health Inc:

  • The MRQ is 0.697. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.641. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.697TTM0.641+0.056
TTM0.641YOY0.601+0.040
TTM0.6415Y0.613+0.029
5Y0.61310Y0.6130.000
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6970.941-0.244
TTM0.6410.961-0.320
YOY0.6011.037-0.436
5Y0.6131.182-0.569
10Y0.6131.125-0.512

1.4. Solvency of NeuPath Health Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Neupath assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Neupath to Medical Care Facilities industry mean.
  • A Debt to Asset Ratio of 0.47 means that Neupath assets are financed with 47.1% credit (debt) and the remaining percentage (100% - 47.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of NeuPath Health Inc:

  • The MRQ is 0.471. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.500. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.471TTM0.500-0.030
TTM0.500YOY0.500+0.000
TTM0.5005Y0.513-0.012
5Y0.51310Y0.5130.000
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4710.543-0.072
TTM0.5000.548-0.048
YOY0.5000.518-0.018
5Y0.5130.564-0.051
10Y0.5130.533-0.020
1.4.2. Debt to Equity Ratio

Measures if Neupath is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Neupath to the Medical Care Facilities industry mean.
  • A Debt to Equity ratio of 88.1% means that company has $0.88 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of NeuPath Health Inc:

  • The MRQ is 0.881. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.997. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.881TTM0.997-0.115
TTM0.997YOY1.000-0.004
TTM0.9975Y1.123-0.126
5Y1.12310Y1.1230.000
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8810.928-0.047
TTM0.9970.960+0.037
YOY1.0001.061-0.061
5Y1.1231.214-0.091
10Y1.1231.198-0.075

2. Market Valuation of NeuPath Health Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Neupath generates.

  • Above 15 is considered overpriced but always compare Neupath to the Medical Care Facilities industry mean.
  • A PE ratio of 5.97 means the investor is paying $5.97 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of NeuPath Health Inc:

  • The EOD is 6.343. Based on the earnings, the company is cheap. +2
  • The MRQ is 5.970. Based on the earnings, the company is cheap. +2
  • The TTM is 6.898. Based on the earnings, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD6.343MRQ5.970+0.373
MRQ5.970TTM6.898-0.928
TTM6.898YOY-7.689+14.587
TTM6.8985Y-6.203+13.101
5Y-6.20310Y-6.2030.000
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
EOD6.34312.025-5.682
MRQ5.97010.707-4.737
TTM6.89813.872-6.974
YOY-7.68911.719-19.408
5Y-6.20313.630-19.833
10Y-6.20319.337-25.540
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of NeuPath Health Inc:

  • The EOD is 6.481. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 6.100. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is -0.502. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD6.481MRQ6.100+0.381
MRQ6.100TTM-0.502+6.602
TTM-0.502YOY-3.721+3.218
TTM-0.5025Y0.381-0.884
5Y0.38110Y0.3810.000
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
EOD6.4818.841-2.360
MRQ6.1007.243-1.143
TTM-0.5026.347-6.849
YOY-3.7215.533-9.254
5Y0.3816.145-5.764
10Y0.3815.110-4.729
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Neupath is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Care Facilities industry mean).
  • A PB ratio of 0.41 means the investor is paying $0.41 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of NeuPath Health Inc:

  • The EOD is 0.432. Based on the equity, the company is cheap. +2
  • The MRQ is 0.406. Based on the equity, the company is cheap. +2
  • The TTM is 0.401. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.432MRQ0.406+0.025
MRQ0.406TTM0.401+0.005
TTM0.401YOY0.821-0.421
TTM0.4015Y0.862-0.461
5Y0.86210Y0.8620.000
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
EOD0.4321.971-1.539
MRQ0.4062.117-1.711
TTM0.4012.028-1.627
YOY0.8212.291-1.470
5Y0.8622.374-1.512
10Y0.8622.685-1.823
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of NeuPath Health Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.008-0.006+171%-0.014+277%0.026-69%0.026-69%
Book Value Per Share--0.3940.387+2%0.439-10%0.400-2%0.400-2%
Current Ratio--1.0640.924+15%0.989+8%1.035+3%1.035+3%
Debt To Asset Ratio--0.4710.500-6%0.500-6%0.513-8%0.513-8%
Debt To Equity Ratio--0.8810.997-12%1.000-12%1.123-22%1.123-22%
Dividend Per Share----0%-0%-0%-0%
Eps--0.007-0.007+205%-0.014+302%-0.014+316%-0.014+316%
Free Cash Flow Per Share--0.0070.012-47%-0.004+156%0.002+264%0.002+264%
Free Cash Flow To Equity Per Share---0.025-0.003-88%-0.019-24%0.000-11346%0.000-11346%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--0.925--------
Intrinsic Value_10Y_min--0.770--------
Intrinsic Value_1Y_max--0.018--------
Intrinsic Value_1Y_min--0.018--------
Intrinsic Value_3Y_max--0.111--------
Intrinsic Value_3Y_min--0.105--------
Intrinsic Value_5Y_max--0.273--------
Intrinsic Value_5Y_min--0.248--------
Market Cap9565543.000+6%9002864.0008721528.750+3%20537783.500-56%20631564.467-56%20631564.467-56%
Net Profit Margin--0.023-0.025+205%-0.049+311%-0.060+356%-0.060+356%
Operating Margin----0.0020%-0.0310%-0.0170%-0.0170%
Operating Ratio--1.8171.814+0%1.857-2%1.830-1%1.830-1%
Pb Ratio0.432+6%0.4060.401+1%0.821-51%0.862-53%0.862-53%
Pe Ratio6.343+6%5.9706.898-13%-7.689+229%-6.203+204%-6.203+204%
Price Per Share0.170+6%0.1600.155+3%0.365-56%0.367-56%0.367-56%
Price To Free Cash Flow Ratio6.481+6%6.100-0.502+108%-3.721+161%0.381+1500%0.381+1500%
Price To Total Gains Ratio20.975+6%19.7415.150+283%-29.238+248%-25.139+227%-25.139+227%
Quick Ratio--0.6970.641+9%0.601+16%0.613+14%0.613+14%
Return On Assets--0.009-0.009+196%-0.015+272%-0.018+303%-0.018+303%
Return On Equity--0.017-0.018+208%-0.031+284%-0.041+341%-0.041+341%
Total Gains Per Share--0.008-0.006+171%-0.014+277%0.026-69%0.026-69%
Usd Book Value--16318616.90016014156.850+2%18192684.475-10%16578285.367-2%16578285.367-2%
Usd Book Value Change Per Share--0.006-0.004+171%-0.011+277%0.019-69%0.019-69%
Usd Book Value Per Share--0.2900.285+2%0.323-10%0.295-2%0.295-2%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.005-0.005+205%-0.010+302%-0.011+316%-0.011+316%
Usd Free Cash Flow--271694.700513201.100-47%-153150.400+156%74611.733+264%74611.733+264%
Usd Free Cash Flow Per Share--0.0050.009-47%-0.003+156%0.001+264%0.001+264%
Usd Free Cash Flow To Equity Per Share---0.018-0.002-88%-0.014-24%0.000-11346%0.000-11346%
Usd Market Cap7043109.311+6%6628808.7636421661.619+3%15121969.991-56%15191020.917-56%15191020.917-56%
Usd Price Per Share0.125+6%0.1180.114+3%0.269-56%0.270-56%0.270-56%
Usd Profit--277585.100-290470.350+205%-561428.750+302%-598660.987+316%-598660.987+316%
Usd Revenue--11843385.50012033166.825-2%11441549.775+4%10820762.973+9%10820762.973+9%
Usd Total Gains Per Share--0.006-0.004+171%-0.011+277%0.019-69%0.019-69%
 EOD+4 -4MRQTTM+22 -10YOY+22 -105Y+18 -1410Y+18 -14

3.2. Fundamental Score

Let's check the fundamental score of NeuPath Health Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-156.343
Price to Book Ratio (EOD)Between0-10.432
Net Profit Margin (MRQ)Greater than00.023
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.697
Current Ratio (MRQ)Greater than11.064
Debt to Asset Ratio (MRQ)Less than10.471
Debt to Equity Ratio (MRQ)Less than10.881
Return on Equity (MRQ)Greater than0.150.017
Return on Assets (MRQ)Greater than0.050.009
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of NeuPath Health Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.686
Ma 20Greater thanMa 500.181
Ma 50Greater thanMa 1000.179
Ma 100Greater thanMa 2000.179
OpenGreater thanClose0.180
Total3/5 (60.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-09-302022-12-312023-03-312023-06-302023-09-30
Net Working Capital  -2,597-192-2,7891,044-1,7451,344-4011,045644
Total Other Income Expense Net -452-1,068-1,5201,489-3110-21739718



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in CAD. All numbers in thousands.

Summary
Total Assets41,888
Total Liabilities19,725
Total Stockholder Equity22,379
 As reported
Total Liabilities 19,725
Total Stockholder Equity+ 22,379
Total Assets = 41,888

Assets

Total Assets41,888
Total Current Assets10,657
Long-term Assets31,231
Total Current Assets
Cash And Cash Equivalents 3,043
Net Receivables 6,979
Other Current Assets 635
Total Current Assets  (as reported)10,657
Total Current Assets  (calculated)10,657
+/-0
Long-term Assets
Property Plant Equipment 9,016
Goodwill 20,718
Intangible Assets 833
Long-term Assets Other 664
Long-term Assets  (as reported)31,231
Long-term Assets  (calculated)31,231
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities10,013
Long-term Liabilities9,712
Total Stockholder Equity22,379
Total Current Liabilities
Short Long Term Debt 996
Accounts payable 7,358
Total Current Liabilities  (as reported)10,013
Total Current Liabilities  (calculated)8,354
+/- 1,659
Long-term Liabilities
Long term Debt 4,620
Capital Lease Obligations Min Short Term Debt6,361
Long-term Liabilities  (as reported)9,712
Long-term Liabilities  (calculated)10,981
+/- 1,269
Total Stockholder Equity
Total Stockholder Equity (as reported)22,379
Total Stockholder Equity (calculated)0
+/- 22,379
Other
Capital Stock44,123
Common Stock Shares Outstanding 56,268
Net Debt 2,573
Net Invested Capital 27,995
Net Working Capital 644
Property Plant and Equipment Gross 9,016



Balance Sheet

Currency in CAD. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-31
> Total Assets 
35,902
38,773
37,213
46,120
52,987
51,606
52,264
51,342
50,059
48,484
47,876
45,086
43,799
43,556
41,888
41,88843,55643,79945,08647,87648,48450,05951,34252,26451,60652,98746,12037,21338,77335,902
   > Total Current Assets 
7,203
10,725
9,816
19,328
17,323
16,732
16,302
15,365
14,283
12,633
11,698
11,081
11,342
11,668
10,657
10,65711,66811,34211,08111,69812,63314,28315,36516,30216,73217,32319,3289,81610,7257,203
       Cash And Cash Equivalents 
477
3,289
2,338
10,850
7,484
6,109
6,006
5,903
4,294
2,858
1,785
1,517
632
2,487
3,043
3,0432,4876321,5171,7852,8584,2945,9036,0066,1097,48410,8502,3383,289477
       Net Receivables 
6,093
6,868
6,879
7,844
9,027
8,382
8,008
8,474
8,988
7,608
7,763
8,894
7,798
7,617
6,979
6,9797,6177,7988,8947,7637,6088,9888,4748,0088,3829,0277,8446,8796,8686,093
       Other Current Assets 
633
568
599
634
812
2,241
2,288
988
1,001
2,167
2,150
670
2,912
529
635
6355292,9126702,1502,1671,0019882,2882,241812634599568633
   > Long-term Assets 
28,699
28,048
27,397
26,792
35,664
34,874
35,962
35,977
35,776
35,851
36,178
34,005
32,457
31,888
31,231
31,23131,88832,45734,00536,17835,85135,77635,97735,96234,87435,66426,79227,39728,04828,699
       Property Plant Equipment 
7,829
7,438
7,043
6,633
12,215
11,708
11,336
11,599
11,516
11,492
11,909
11,541
10,075
9,661
9,016
9,0169,66110,07511,54111,90911,49211,51611,59911,33611,70812,2156,6337,0437,4387,829
       Goodwill 
18,970
18,970
18,970
18,970
20,718
20,718
20,718
20,718
20,718
20,718
20,718
20,718
20,718
20,718
20,718
20,71820,71820,71820,71820,71820,71820,71820,71820,71820,71820,71818,97018,97018,97018,970
       Intangible Assets 
1,503
1,273
1,047
884
1,918
1,725
3,235
3,053
2,989
3,129
3,056
1,003
939
886
833
8338869391,0033,0563,1292,9893,0533,2351,7251,9188841,0471,2731,503
       Other Assets 
397
367
337
305
813
723
673
607
553
512
495
743
0
0
0
000743495512553607673723813305337367397
> Total Liabilities 
26,936
20,981
19,650
18,496
25,988
25,340
25,570
25,512
25,119
23,881
24,416
23,433
22,324
21,849
19,725
19,72521,84922,32423,43324,41623,88125,11925,51225,57025,34025,98818,49619,65020,98126,936
   > Total Current Liabilities 
17,586
11,876
10,796
9,980
13,635
13,342
13,715
13,708
13,785
12,874
14,295
13,870
13,087
12,069
10,013
10,01312,06913,08713,87014,29512,87413,78513,70813,71513,34213,6359,98010,79611,87617,586
       Short Long Term Debt 
8,323
3,591
3,391
3,091
4,686
4,255
3,945
3,441
3,038
2,735
3,496
3,092
2,791
2,511
996
9962,5112,7913,0923,4962,7353,0383,4413,9454,2554,6863,0913,3913,5918,323
       Accounts payable 
4,684
6,198
5,515
5,612
7,520
7,647
7,983
7,534
8,592
7,963
7,909
8,800
8,415
7,778
7,358
7,3587,7788,4158,8007,9097,9638,5927,5347,9837,6477,5205,6125,5156,1984,684
       Other Current Liabilities 
2,333
662
565
0
75
66
417
611
812
876
927
432
0
0
0
000432927876812611417667505656622,333
   > Long-term Liabilities 
9,350
9,105
8,854
8,516
12,353
11,998
11,855
11,804
11,334
11,007
10,121
9,563
9,237
9,780
9,712
9,7129,7809,2379,56310,12111,00711,33411,80411,85511,99812,3538,5168,8549,1059,350
       Long term Debt 
1,180
1,213
1,246
4,912
1,310
1,303
1,298
4,961
1,279
1,271
160
3,674
3,674
4,405
4,620
4,6204,4053,6743,6741601,2711,2794,9611,2981,3031,3104,9121,2461,2131,180
       Capital Lease Obligations Min Short Term Debt
5,447
5,197
4,938
4,672
8,325
7,997
7,766
8,000
7,659
7,297
7,622
7,402
7,024
6,762
6,361
6,3616,7627,0247,4027,6227,2977,6598,0007,7667,9978,3254,6724,9385,1975,447
       Other Liabilities 
96
96
96
59
398
398
487
215
65
65
65
33
0
0
0
0003365656521548739839859969696
       Long-term Liabilities Other 
0
0
0
0
0
0
150
150
0
0
0
0
0
0
0
0000000150150000000
> Total Stockholder Equity
8,966
17,792
17,563
27,624
26,999
26,266
26,694
25,830
24,943
24,634
23,549
21,784
21,639
21,902
22,379
22,37921,90221,63921,78423,54924,63424,94325,83026,69426,26626,99927,62417,56317,7928,966
   Common Stock
11,527
23,473
23,473
32,825
35,856
35,856
36,830
36,830
36,830
37,205
39,923
39,923
0
0
0
00039,92339,92337,20536,83036,83036,83035,85635,85632,82523,47323,47311,527
   Retained Earnings -25,653-26,030-26,107-25,915-24,097-23,016-22,678-21,771-21,051-20,391-19,243-18,541-17,954-17,664-14,313
   Capital Surplus 000000000000000
   Treasury Stock000000000000000
   Other Stockholders Equity 
11,653
11,727
11,727
12,910
9,347
9,347
9,345
9,156
9,156
8,933
6,081
4,882
0
0
0
0004,8826,0818,9339,1569,1569,3459,3479,34712,91011,72711,72711,653



Balance Sheet

Currency in CAD. All numbers in thousands.




Cash Flow

Currency in CAD. All numbers in thousands.




Income Statement

Currency in CAD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue65,371
Cost of Revenue-53,492
Gross Profit11,87911,879
 
Operating Income (+$)
Gross Profit11,879
Operating Expense-65,049
Operating Income322-53,170
 
Operating Expense (+$)
Research Development-
Selling General Administrative9,023
Selling And Marketing Expenses-
Operating Expense65,0499,023
 
Net Interest Income (+$)
Interest Income12
Interest Expense-875
Other Finance Cost-0
Net Interest Income-863
 
Pretax Income (+$)
Operating Income322
Net Interest Income-863
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-1,3951,176
EBIT - interestExpense = -875
-1,578
-703
Interest Expense875
Earnings Before Interest and Taxes (EBIT)--520
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-1,395
Tax Provision-288
Net Income From Continuing Ops-1,683-1,683
Net Income-1,578
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-854863
 

Technical Analysis of Neupath
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Neupath. The general trend of Neupath is BULLISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Neupath's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (14.3%) Bearish trend (-14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of NeuPath Health Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.195 < 0.195 < 0.195.

The bearish price targets are: 0.17 > 0.17 > 0.17.

Tweet this
NeuPath Health Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of NeuPath Health Inc. The current mas is .

The long score for the Moving Averages is 8/14.
The longshort score for the Moving Averages is 2/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

NeuPath Health Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of NeuPath Health Inc. The current macd is -0.00193171.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Neupath price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Neupath. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Neupath price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
NeuPath Health Inc Daily Moving Average Convergence/Divergence (MACD) ChartNeuPath Health Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of NeuPath Health Inc. The current adx is 13.07.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Neupath shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
NeuPath Health Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of NeuPath Health Inc. The current sar is 0.19823576.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
NeuPath Health Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of NeuPath Health Inc. The current rsi is 43.69. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
NeuPath Health Inc Daily Relative Strength Index (RSI) ChartNeuPath Health Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of NeuPath Health Inc. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Neupath price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
NeuPath Health Inc Daily Stochastic Oscillator ChartNeuPath Health Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of NeuPath Health Inc. The current cci is -84.65608466.

NeuPath Health Inc Daily Commodity Channel Index (CCI) ChartNeuPath Health Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of NeuPath Health Inc. The current cmo is -16.40076704.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
NeuPath Health Inc Daily Chande Momentum Oscillator (CMO) ChartNeuPath Health Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of NeuPath Health Inc. The current willr is -100.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
NeuPath Health Inc Daily Williams %R ChartNeuPath Health Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of NeuPath Health Inc.

NeuPath Health Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of NeuPath Health Inc. The current atr is 0.00714189.

NeuPath Health Inc Daily Average True Range (ATR) ChartNeuPath Health Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of NeuPath Health Inc. The current obv is -3,966,976.

NeuPath Health Inc Daily On-Balance Volume (OBV) ChartNeuPath Health Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of NeuPath Health Inc. The current mfi is 26.72.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
NeuPath Health Inc Daily Money Flow Index (MFI) ChartNeuPath Health Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for NeuPath Health Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-11-10ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-11-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-11-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-23STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-11-29MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-30STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-03MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-10MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-18MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-23MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-01MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-07ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-25CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

NeuPath Health Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of NeuPath Health Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5043.686
Ma 20Greater thanMa 500.181
Ma 50Greater thanMa 1000.179
Ma 100Greater thanMa 2000.179
OpenGreater thanClose0.180
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Neupath with someone you think should read this too:
  • Are you bullish or bearish on Neupath? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Neupath? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about NeuPath Health Inc

I send you an email if I find something interesting about NeuPath Health Inc.


Comments

How you think about this?

Leave a comment

Stay informed about NeuPath Health Inc.

Receive notifications about NeuPath Health Inc in your mailbox!